These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Proteomics Applications in Health: Biomarker and Drug Discovery and Food Industry. Amiri-Dashatan N; Koushki M; Abbaszadeh HA; Rostami-Nejad M; Rezaei-Tavirani M Iran J Pharm Res; 2018; 17(4):1523-1536. PubMed ID: 30568709 [TBL] [Abstract][Full Text] [Related]
4. Proteomics in biomarker discovery and drug development. He QY; Chiu JF J Cell Biochem; 2003 Aug; 89(5):868-86. PubMed ID: 12874822 [TBL] [Abstract][Full Text] [Related]
5. Erratum: Eyestalk Ablation to Increase Ovarian Maturation in Mud Crabs. J Vis Exp; 2023 May; (195):. PubMed ID: 37235796 [TBL] [Abstract][Full Text] [Related]
6. Advances in Current Diabetes Proteomics: From the Perspectives of Label- free Quantification and Biomarker Selection. Fu J; Luo Y; Mou M; Zhang H; Tang J; Wang Y; Zhu F Curr Drug Targets; 2020; 21(1):34-54. PubMed ID: 31433754 [TBL] [Abstract][Full Text] [Related]
7. Proteomics in nutrition and health. Kussmann M; Affolter M; Fay LB Comb Chem High Throughput Screen; 2005 Dec; 8(8):679-96. PubMed ID: 16464156 [TBL] [Abstract][Full Text] [Related]
8. Application of cutting-edge proteomics technologies for elucidating host-bacteria interactions. Petriz BA; Franco OL Adv Protein Chem Struct Biol; 2014; 95():1-24. PubMed ID: 24985768 [TBL] [Abstract][Full Text] [Related]
9. Biomarker discovery: proteome fractionation and separation in biological samples. Matt P; Fu Z; Fu Q; Van Eyk JE Physiol Genomics; 2008 Mar; 33(1):12-7. PubMed ID: 18162500 [TBL] [Abstract][Full Text] [Related]
10. Contribution of oncoproteomics to cancer biomarker discovery. Cho WC Mol Cancer; 2007 Apr; 6():25. PubMed ID: 17407558 [TBL] [Abstract][Full Text] [Related]
11. Proteomic approaches in biological and medical sciences: principles and applications. Conrotto P; Souchelnytskyi S Exp Oncol; 2008 Sep; 30(3):171-80. PubMed ID: 18806738 [TBL] [Abstract][Full Text] [Related]
12. Plasma proteomic analysis reveals altered protein abundances in cardiovascular disease. Lygirou V; Latosinska A; Makridakis M; Mullen W; Delles C; Schanstra JP; Zoidakis J; Pieske B; Mischak H; Vlahou A J Transl Med; 2018 Apr; 16(1):104. PubMed ID: 29665821 [TBL] [Abstract][Full Text] [Related]
13. Proteomics: Concepts and applications in human medicine. Al-Amrani S; Al-Jabri Z; Al-Zaabi A; Alshekaili J; Al-Khabori M World J Biol Chem; 2021 Sep; 12(5):57-69. PubMed ID: 34630910 [TBL] [Abstract][Full Text] [Related]
14. Clinical proteomics for cancer biomarker discovery and therapeutic targeting. Krieg RC; Paweletz CP; Liotta LA; Petricoin EF Technol Cancer Res Treat; 2002 Aug; 1(4):263-72. PubMed ID: 12625785 [TBL] [Abstract][Full Text] [Related]
15. Activity-based protein profiling: applications to biomarker discovery, in vivo imaging and drug discovery. Berger AB; Vitorino PM; Bogyo M Am J Pharmacogenomics; 2004; 4(6):371-81. PubMed ID: 15651898 [TBL] [Abstract][Full Text] [Related]
16. Application of proteomic data in the translation of in vitro observations to associated clinical outcomes. Neuhoff S; Harwood MD; Rostami-Hodjegan A; Achour B Drug Discov Today Technol; 2021 Dec; 39():13-22. PubMed ID: 34906322 [TBL] [Abstract][Full Text] [Related]
17. Proteomics in the pharmaceutical and biotechnology industry: a look to the next decade. Lill JR; Mathews WR; Rose CM; Schirle M Expert Rev Proteomics; 2021 Jul; 18(7):503-526. PubMed ID: 34320887 [TBL] [Abstract][Full Text] [Related]